|1.||Bian, Xiu-wu: 6 articles (06/2011 - 02/2007)|
|2.||Ping, Yi-fang: 5 articles (06/2011 - 02/2007)|
|3.||Chen, Jian-hong: 5 articles (09/2007 - 02/2007)|
|4.||Bian, Xiu-Wu: 4 articles (08/2008 - 04/2006)|
|5.||Wang, Ji Ming: 4 articles (02/2008 - 08/2007)|
|6.||Zhou, Xiang-dong: 4 articles (09/2007 - 08/2007)|
|7.||Zhou, Xiang-Dong: 3 articles (02/2008 - 04/2006)|
|8.||Chen, Jian-Hong: 3 articles (02/2008 - 04/2006)|
|9.||Yao, Xiao-hong: 3 articles (09/2007 - 02/2007)|
|10.||Liu, Hong: 3 articles (09/2007 - 08/2007)|
02/01/2008 - "In this study, we found that Nordy inhibited the growth of human glioma cell lines in vitro and their tumorigenicity in mice. "
02/01/2008 - "In addition, Nordy promoted differentiation of highly malignant human glioma cells. "
03/01/2007 - "[Effect of nordy on FPR function of malignant human glioma cell line U87]."
04/21/2006 - "Our results suggest that Nordy was capable of reducing the level of malignancy of glioma cells."
04/21/2006 - "In U87 glioma cells, the expression of FPR was attenuated at the protein level by Nordy treatment for 48 (P<0.05). "
|2.||Glioblastoma (Glioblastoma Multiforme)
08/01/2007 - "Further study revealed that the effect of Nordy was attributable to its down-regulation of the expression of functional CXCR4 in glioblastoma cells. "
08/01/2007 - "In this study we examined the capacity of Nordy to regulate CXCR4-mediated production of angiogenic factors by human glioblastoma cells. "
09/01/2007 - "Nordy promotes the differentiation of glioblastoma cells, by which it may serve as a therapeutic agent. "
09/01/2007 - "Glioblastoma U87MG cells were induced to differentiate by synthetic lipoxygenase inhibitor, Nordy. "
09/01/2007 - "To explore effects of nordy on biological behaviors of human malignant glioblastoma cell line U87MG in vitro and transplanted tumor in vivo, and to identify the differential proteome upon Nordy induced differentiation. "
08/01/2008 - "The results suggested that Nordy might be a potential tumor therapeutic agent."
02/01/2008 - "Investigation into the mechanistic basis of Nordy activities revealed that it altered the pattern of protein expression profiles in tumor cells. "
09/01/2007 - "Nordy suppressed both the proliferation of U87MG cells in vitro and the tumor growth of orthotopic transplanted tumors in vivo (P < 0.01). "
09/01/2007 - "Thus, Nordy may constitute a molecular basis for the development of novel anti-cancer drugs."
03/01/2007 - "Nordy could inhibit FPR functioning in glioma cell proliferation, migration and angiogenesis, which might be a possible mechanism of its anti-cancer effects."
|1.||Nordihydroguaiaretic Acid (Masoprocol)
|4.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|5.||Interleukin-8 (Interleukin 8)
|6.||Messenger RNA (mRNA)
|9.||Angiogenesis Inducing Agents (Angiogenesis Factor)
|1.||Heterologous Transplantation (Xenotransplantation)